Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
Bayer Aktiengesellschaft is a member of our Medical group, which includes 997 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BAYRY's full-year earnings has moved 9.4% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, BAYRY has gained about 45.3% so far this year. Meanwhile, stocks in the Medical group have lost about 5.8% on average. This means that Bayer Aktiengesellschaft is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is BioCryst Pharmaceuticals (BCRX). The stock is up 43.5% year-to-date.
For BioCryst Pharmaceuticals, the consensus EPS estimate for the current year has increased 359.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry, a group that includes 11 individual stocks and currently sits at #41 in the Zacks Industry Rank. Stocks in this group have lost about 4.3% so far this year, so BAYRY is performing better this group in terms of year-to-date returns.
On the other hand, BioCryst Pharmaceuticals belongs to the Medical - Drugs industry. This 161-stock industry is currently ranked #56. The industry has moved -0.9% year to date.
Investors interested in the Medical sector may want to keep a close eye on Bayer Aktiengesellschaft and BioCryst Pharmaceuticals as they attempt to continue their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report
BioCryst Pharmaceuticals, Inc. (BCRX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Here's What Key Metrics Tell Us About Loar Holdings Inc. (LOAR) Q2 Earnings
Loar Holdings Inc. (LOAR) reported $123.12 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 26.9%. EPS of $0.23 for the same period compares to $0.13 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $120.28 million, representing a surprise of +2.37%. The company delivered an EPS surprise of +21.05%, with the consensus EPS estimate being $0.19. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Loar Holdings Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: OEM Net Sales- Total: $54.32 million compared to the $51.62 million average estimate based on two analysts. Total Net Sales- Other: $7.21 million compared to the $7.32 million average estimate based on two analysts. OEM Net Sales- Commercial- Commercial Aerospace: $19.44 million compared to the $18.4 million average estimate based on two analysts. OEM Net Sales- Commercial- Business Jet and General Aviation: $17.9 million compared to the $19.05 million average estimate based on two analysts. OEM Net Sales- Total Commercial: $37.34 million versus the two-analyst average estimate of $37.45 million. OEM Net Sales- Defense: $14.33 million versus the two-analyst average estimate of $10.98 million. OEM Net Sales- Other: $2.66 million versus the two-analyst average estimate of $3.19 million. Aftermarket Net Sales- Commercial- Commercial Aerospace: $34.84 million versus the two-analyst average estimate of $36.54 million. Aftermarket Net Sales- Commercial- Business Jet and General Aviation: $12.27 million compared to the $11.24 million average estimate based on two analysts. Aftermarket Net Sales- Total Commercial: $47.1 million versus $47.78 million estimated by two analysts on average. Aftermarket Net Sales- Defense: $17.14 million compared to the $16.76 million average estimate based on two analysts. Aftermarket Net Sales- Other: $4.56 million versus the two-analyst average estimate of $4.12 million. View all Key Company Metrics for Loar Holdings Inc. here>>> Shares of Loar Holdings Inc. have returned -8.7% over the past month versus the Zacks S&P 500 composite's +3.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Loar Holdings Inc. (LOAR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Here's What Investors Should Expect From RADCOM's Q2 Earnings
RADCOM Ltd. (RDCM) is slated to report second-quarter 2025 results on Aug. 13, before market open. The Zacks Consensus Estimate for revenues is $17 million, suggesting 14.9% growth from the year-ago quarter's reported figure. The consensus estimate for earnings is pegged at 22 cents per share, unchanged in the past 60 days, indicating an increase of 10% from the year-ago quarter's reported figure. RDCM's earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 22.3%. Shares of the company have gained 32.7% in the past year compared with the Zacks Computer - Networking industry's growth of 54.4%. Image Source: Zacks Investment Research Factors at Play RADCOM's focus on AI, 5G assurance and cloud-native solutions is likely to have driven its growth trajectory in the second quarter. Continued margin strength and visibility into new AI/5G contract traction bolsters its momentum with the flagship guidance raised. RDCM's key strength lies in its automated, AI-driven assurance platform, RADCOM ACE, which provides real-time insights and data on service performance and customer experience. Moving forward, it anticipates increasing demand for its data and insights as new AI-driven use cases continue to emerge. Management is investing in agentic AI by partnering with leading customer care, service management and orchestration platforms to enable fully automated, customer experience–focused workflows. These include live call center issue resolution, managing network incidents with real-time impact analysis and supporting network orchestration and optimization. It views agentic AI as a step beyond siloed automation, promoting a collaborative telecom ecosystem. Apart from this, RDCM is investing in key areas tied to its core strengths, including using accelerated computing and GenAI to deliver high-capacity, real-time user and service insights. These span customer experience and usage metrics to advanced intent models that predict satisfaction and potential complaints. The company focuses on key partnerships to accelerate its vision for bringing real-time customer insights to the service assurance market and augmenting its market footprint. It has partnered with ServiceNow to deliver AI-driven complaint resolution and predictive customer experience, becoming one of the first to integrate with its AI Agent Fabric for seamless workflows. Radcom Ltd. Price and EPS Surprise Radcom Ltd. price-eps-surprise | Radcom Ltd. Quote The global telecom market is growing, driven by 5G standalone networks and high-value use cases like IoT, private 5G and mission-critical services. As AI-driven digital grids emerge, telecom providers play a key role in enabling this transformation, making scalable 5G networks essential for next-gen applications. Operators are adopting AI, including agentic AI, to improve productivity, efficiency and cost management. With its advanced user analytics and expertise, RADCOM is well-positioned to meet the data demands of this shift. Another major opportunity comes from the industry's move toward open architecture. Rising adoption of open AI frameworks powered by multimodal, multi-domain technology integration is driving this shift. This trend positions RADCOM to support operators in delivering real-time, intelligent user experiences. However, higher expenses to support a growing pipeline and expand regional coverage are likely to have pressured margins. Management also remains cautious about broader macro challenges, including forex fluctuations, geopolitical risks and intense competition. Key Recent Development In May 2025, RADCOM inked a multi-year, eight-figure contract renewal with a top North American telecom operator, bolstering its position in ensuring network performance and service quality. What Our Model Predicts for RDCM Our proven model does not predict an earnings beat for RDCM this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case here. RDCM currently has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. Stocks With the Favorable Combination Here are three stocks you may want to consider, as our model shows that these have the right elements to post an earnings beat in this reporting cycle. Affirm Holdings (AFRM) presently has an Earnings ESP of +19.25% and a Zacks Rank #3. You can see the complete list of today's Zacks #1 Rank stocks here The Zacks Consensus Estimate for revenues and earnings is pegged at $840 million and 11 cents per share. Affirm is scheduled to report its fourth-quarter fiscal 2025 results on Aug. 28. NICE (NICE) has an Earnings ESP of +0.88% and has a Zacks Rank of #3 at present. The Zacks Consensus Estimate for revenues and earnings is pegged at $714 million and $2.99 per share. NICE is set to report its second-quarter 2025 results on Aug. 14. Analog Devices (ADI) has an Earnings ESP of +0.72% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for revenues and earnings is pegged at $2.76 billion and $1.93 per share. Analog Devices is scheduled to report its third-quarter fiscal 2025 results on Aug. 20. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Analog Devices, Inc. (ADI) : Free Stock Analysis Report Nice (NICE) : Free Stock Analysis Report Radcom Ltd. (RDCM) : Free Stock Analysis Report Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Sapiens (SPNS) Surpasses Q2 Earnings and Revenue Estimates
Sapiens (SPNS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +6.25%. A quarter ago, it was expected that this provider of software and services to the insurance industry would post earnings of $0.35 per share when it actually produced earnings of $0.37, delivering a surprise of +5.71%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Sapiens, which belongs to the Zacks Computer - Software industry, posted revenues of $141.6 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.07%. This compares to year-ago revenues of $136.8 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Sapiens shares have added about 9.8% since the beginning of the year versus the S&P 500's gain of 9.6%. What's Next for Sapiens? While Sapiens has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Sapiens was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.35 on $148.8 million in revenues for the coming quarter and $1.39 on $575.25 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computer - Software is currently in the top 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. (CRM), another stock in the same industry, has yet to report results for the quarter ended July 2025. The results are expected to be released on September 3. This customer-management software developer is expected to post quarterly earnings of $2.77 per share in its upcoming report, which represents a year-over-year change of +8.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. revenues are expected to be $10.13 billion, up 8.7% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report Salesforce Inc. (CRM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
